Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Emcure Pharmaceuticals Ltd
EMCURE | NSE
1,493.65
INR10.55
0.71%
EMCURE | NSE
About Emcure Pharmaceuticals Ltd
Sector
IN
Industry
IN
Earnings date
01/01/1970
As of date
18/10/2024
Close
1,493.65
Open
1,462.00
High
1,505.35
Low
1,462.00
View Less
EMCURE | NSE
Risk
45.7
Sharpe
0
Luna's Score
49/100
Recommendation
Hold
Luna says (EMCURE | NSE)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
High Short-term Volatility
Midcap (2B - 10B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
56.4%1 month
45.7%3 months
35.7%6 months
34.5%Returns
Fundamental Ratios
PE
54.29
Fwd. PE
-
Price to book
9.39
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
22.49
Ent. to rev.
4.66
PEG
-
Other Fundamentals
EBITDA
12.05B
MarketCap
275.72B
MarketCap(USD)
3.32B
Div. yield
-
Op. margin
13.37
Erngs. growth
10.30
Rev. growth
16.60
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
208.90
Range1M
255.95
Range3M
355.00
Volumes: Market Activity
Rel. volume
0.53
Price X volume
135.53M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 22.49 | 38.27 | Cheaper |
| Ent. to Revenue | 4.66 | 10.34 | Cheaper |
| PE Ratio | 54.29 | 60.68 | Par |
| Price to Book | 9.39 | 9.15 | Par |
| Dividend Yield | - | 0.66 | - |
| Std. Deviation (3M) | 35.70 | 43.73 | Par |
| Debt to Equity | - | 0.59 | - |
| Debt to Assets | - | 0.20 | - |
| Market Cap | 275.72B | 104.65B | Market Leader |
